Press Releases
Press Releases 2008
Press Releases 2007
Press Releases 2006
Press Releases 2005
Press Releases 2004
Press Releases 2003
Press Releases 2002 and earlier
Press Releases
If you wish to be informed regularly about MediGene's press releases, you can subscribe to our investor's newsletter.


Suchen Alles

MediGene Increases Revenues and Reduces Net Cash Burn Rate in the First Six Months of 2008 

 01-08-2008
MediGene Sells Licensee Rights to the Drug Oracea® to Galderma 

 31-07-2008
European Commission Grants Marketing Authorization for Oracea® 

 29-07-2008
MediGene exercises option for Anti-L1 Monoclonal Antibody and continues collaboration with DKFZ (German Cancer Research Center) 

 17-07-2008
MediGene's Annual Shareholders Meeting Elects Two New Supervisory Board Members 

 16-07-2008
MediGene Publishes Update on RhuDex® Incident 

 15-07-2008
MediGene puts clinical phase I study with RhuDex® on hold 

 08-07-2008
MediGene Achieves Positive Results with RhuDex® in Clinical Phase IIa Trial 

 24-06-2008
MediGene to Present at the Piper Jaffray Conference in London 

 20-06-2008
MediGene Focuses its Strategy on Oncology and Immunology 

 02-06-2008
Data from Clinical Trial of MediGene's EndoTAGTM-1 in the Indication Pancreatic Cancer will be presented at ASCO Annual Meeting 

 30-05-2008
MediGene appoints new Executive Board Member for Research & Development 

 21-05-2008
MediGene Presents 3-Months Report 2008 

 09-05-2008
European Regulatory Authority (EMEA) Recommends Granting of Marketing Authorization for MediGene's Drug Oracea® 

 25-04-2008
MediGene Presents Details of the Excellent Clinical Efficacy Data Obtained with EndoTAG(TM)-1 in the Indication Pancreatic Carcinoma 

 07-04-2008
MediGene Announces Telephone Conference Accessible via Webcast on April 7, 2008, to Discuss the Results Obtained in a Clinical Phase II Trial of EndoTAG®-1 

 04-04-2008
MediGene Extends Protection for its Innovative EndoTAG® Technology by Another European Patent 

 02-04-2008
MediGene Achieves Excellent Efficacy Data of EndoTAGTM-1 in Clinical Phase II Trial in Pancreatic Carcinoma 

 17-03-2008
MediGene to Present at the Cowen and Company 28th Annual Health Care Conference in Boston 

 14-03-2008
MediGene AG Announces Consolidated Result for the Year 2007 

 13-03-2008
Within the Scope of the „BioChancePlus“ Competition, MediGene Receives a Research Grant of Approx. 600,000 Euros from the Federal Ministry of Education and Research 

 11-02-2008
MediGene to Present at the BIO CEO & Investor Conference in New York 

 06-02-2008
MediGene to Present Recent Data Obtained in a Clinical Trial of Oncolytic Virus NV1020 on the Occasion of the ASCO GI Symposium 

 25-01-2008
MediGene Focuses its Research Activities and Considers External Financing for mTCR Program 

 07-01-2008

For further information please contact Julia Hofmann or Georg Dönges, Public Relations, MediGene AG

 Contact